Orthofix recently announced net sales at $151 million for the fourth quarter of 2011, a 5 percent increase over the same period last year.
Orthofix also reported full year sales at $579 million. Robert Vaters, president and CEO of Orthofix, said 2011 was a transition year for the company and it is now poised for long term revenue growth across the regenerative and repair products platforms.
The company's spine products were flat during the fourth quarter at $78.6 million, but the orthopedics products grew by 16 percent to $44.5 million. The sports medicine business grew by 10 percent to $27.5 million. The increases were led by external fixation products and international markets.
Related Articles on Orthopedic Devices:
Small Bone Innovations Names Michael Simpson President & CEO
Global Orthopedic Device Market to Reach $61.3B by 2017
ArthroCare Revenues Down in 2011
The company's spine products were flat during the fourth quarter at $78.6 million, but the orthopedics products grew by 16 percent to $44.5 million. The sports medicine business grew by 10 percent to $27.5 million. The increases were led by external fixation products and international markets.
Related Articles on Orthopedic Devices:
Small Bone Innovations Names Michael Simpson President & CEO
Global Orthopedic Device Market to Reach $61.3B by 2017
ArthroCare Revenues Down in 2011